These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
445 related items for PubMed ID: 18771430
1. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial. Juergens CP, Winter JP, Nguyen-Do P, Lo S, French JK, Hallani H, Fernandes C, Jepson N, Leung DY. Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430 [Abstract] [Full Text] [Related]
3. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ. Catheter Cardiovasc Interv; 2008 Dec 01; 72(7):958-65. PubMed ID: 19021282 [Abstract] [Full Text] [Related]
5. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD. JACC Cardiovasc Interv; 2009 May 01; 2(5):415-21. PubMed ID: 19463464 [Abstract] [Full Text] [Related]
7. Nephrotoxic effects in high-risk patients undergoing angiography. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ, Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non-Ionic Contrast Media Study Investigators. N Engl J Med; 2003 Feb 06; 348(6):491-9. PubMed ID: 12571256 [Abstract] [Full Text] [Related]
8. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial). Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C. Am J Cardiol; 2012 Jan 01; 109(1):67-74. PubMed ID: 21943940 [Abstract] [Full Text] [Related]
9. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, Costello P, Schoepf UJ. Radiology; 2008 Jul 01; 248(1):97-105. PubMed ID: 18483232 [Abstract] [Full Text] [Related]
10. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Möckel M, Radovic M, Kühnle Y, Combé V, Waigand J, Schröder S, Dietz R, Frei U, Eckardt KU. Nephrol Dial Transplant; 2008 May 01; 23(5):1588-94. PubMed ID: 18175785 [Abstract] [Full Text] [Related]
11. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. Feldkamp T, Baumgart D, Elsner M, Herget-Rosenthal S, Pietruck F, Erbel R, Philipp T, Kribben A. Clin Nephrol; 2006 Nov 01; 66(5):322-30. PubMed ID: 17140161 [Abstract] [Full Text] [Related]
12. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Adolph E, Holdt-Lehmann B, Chatterjee T, Paschka S, Prott A, Schneider H, Koerber T, Ince H, Steiner M, Schuff-Werner P, Nienaber CA. Coron Artery Dis; 2008 Sep 01; 19(6):413-9. PubMed ID: 18955835 [Abstract] [Full Text] [Related]
14. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study. Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C. J Cardiovasc Med (Hagerstown); 2010 Mar 01; 11(3):199-206. PubMed ID: 19829124 [Abstract] [Full Text] [Related]
18. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial. Terrenato I, Sperati F, Musicco F, Pozzi AF, di Turi A, Caterino M, de Lutio di Castelguidone E, Setola SV, Bellomi M, Neumaier CE, Conti L, Cigliana G, Merola R, Antenucci A, Orlandi G, Giordano A, Barba M, Canitano S. J Cell Physiol; 2018 Mar 01; 233(3):2572-2580. PubMed ID: 28777459 [Abstract] [Full Text] [Related]
19. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats. Ladwig M, Flemming B, Seeliger E, Sargsyan L, Persson PB. Invest Radiol; 2011 Nov 01; 46(11):672-7. PubMed ID: 21623210 [Abstract] [Full Text] [Related]
20. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease. Tadros GM, Malik JA, Manske CL, Kasiske BL, Dickinson SE, Herzog CA, Wilson RF, Das G, Panetta CJ. J Invasive Cardiol; 2005 Apr 01; 17(4):211-5. PubMed ID: 15831975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]